Moreover, LIPA and COL1A2 expression showed a trend towards increasing in parallel with the degree of disease activity, with some significant intergroup differences when NAFLD cases were stratified according to NAS score (Fig. 5E). Here, LIPA is linked to metabolic dysfunction-associated steatotic liver disease.